Viewing Study NCT06006650


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2025-12-25 @ 6:48 PM
Study NCT ID: NCT06006650
Status: RECRUITING
Last Update Posted: 2023-08-23
First Post: 2023-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
Sponsor: Tang-Du Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module